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Objectives: The present study examined the 5- year longitudinal course of cognitive 
functioning in a large sample of well- characterized patients with bipolar disorder (BP), 
compared to healthy controls (HCs), and the influence of cognitive reserve factors 
(e.g., education and IQ) on cognitive change over time.
Methods: Participants included 159 individuals diagnosed with BP and 54 HCs 
 recruited as part of a longitudinal naturalistic study of BP who had completed neu-
ropsychological testing at the time of their enrollment and again 5 years later.
Results: The overall relative rate of change did not differ between the BP and HC 
groups. In total, 46.5% of the BP group and 37% of the HC group showed evidence of 
decline on at least one measure over time. T- test analyses did not find differences 
 between BP ‘decliners’ and ‘non- decliners’ in cognitive reserve variables. However, we 
found that higher baseline intellectual ability was associated with more stability in 
cognitive test scores over time for the BP group. Results of linear regression modeling 
revealed that lower verbal IQ and education were related to increased cognitive 
 decline in specific domains in the BP group.
Conclusions:  This study has explored the influence of cognitive reserve on preserva-
tion of specific cognitive abilities over time in BP. The BP group did not demonstrate 
accelerated cognitive decline over 5 years compared to the HC group. Although the 
trajectory of cognitive change over time was similar between BP patients and HCs, 
higher overall intellectual ability may be a protective factor against cognitive decline, 
particularly for BP patients.
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1  | INTRODUCTION
It has been well established that individuals with bipolar disorder (BP) 
typically achieve lower neuropsychological test scores compared to 
healthy controls (HCs) across a number of cognitive domains, including 
attention, memory, psychomotor speed, and executive functioning.1–4 
However, few studies have examined if and how these cognitive defi-
cits change over time. Past studies have found that older individuals 
with BP tend to have more functional impairment and neurocogni-
tive impairment and higher rates of dementia.5–7 These findings lead 
to the assumption that individuals with BP may be at increased risk 
for cognitive decline and therefore suffer a progressive, accelerated 
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neurodegeneration over time.8,9 Further, previous cross- sectional 
work by our group10 has demonstrated an additive effect of aging and 
cognitive burden on health- related quality of life, as well as evidence 
of an age by BP diagnosis interaction in terms of performance on emo-
tion processing, processing speed, and executive functioning tasks. 
These findings highlight the importance of studying cognitive changes 
in aging individuals affected by BP.
Although relatively sparse, a number of recent articles have pro-
posed that progression of cognitive symptoms over time may not differ 
between individuals diagnosed with BP and HC subjects.11–13 In a re-
cent review article examining longitudinal and cross- sectional research 
on the trajectory of neuropsychological dysfunction among those with 
BP, Strejilevich and colleagues13 concluded that evidence does not 
support progressive neurocognitive decline over time. They noted, 
however, that many of the studies to date had methodological limita-
tions such as small sample size and brief neuropsychological batteries. 
In other recent work, Gildengers and colleagues11 explored longitu-
dinal neuropsychological performances in BP over 2 years and found 
that, although individuals with BP tended to score lower on cognitive 
measures overall, the change in scores did not differ compared to HCs, 
suggesting that BP was not related to an accelerated rate of cognitive 
decline as was previously assumed. Similarly, Santos and colleagues 
analyzed the longitudinal course of BP cognitive trajectory over a lon-
ger time period and again found that BP participants demonstrated a 
similar cognitive trajectory over time compared to controls, despite 
performing at lower levels on neuropsychological testing. Again, these 
findings suggest that having a BP diagnosis was not associated with 
progressive neurocognitive decline. Further, this work reported that 
the clinical symptom course of BP (measured by number of mood ep-
isodes) was unrelated to cognitive performance over time, indicating 
that cognitive deficits in BP tend to be stable, following a course sim-
ilar to that in individuals without a significant psychiatric condition. 
Although compelling, data were obtained in a small sample size of 80 
BP participants, and further exploration with larger samples and over 
longer periods of time is needed to better evaluate this hypothesis. 
As normative age- related changes can be notable and highly variable 
studies finding, a null effect of disease by age are likely underpowered 
with smaller samples over shorter periods of time. Overall, analysis of 
neurocognitive change in BP is a relatively new area of study, and most 
work done in the area has been cross- sectional in nature, utilizes small 
sample sizes over a short follow- up time interval, and has used a brief 
incomprehensive test battery.
While patterns of cognitive dysfunction across BP mood states 
have been found in executive functioning, psychomotor speed, 
 attention, and memory,4 there is a large amount of heterogeneity in 
cognitive profiles and presentations,9 with patients ranging from no 
impairment to substantial impairment.14,15 Many individual differences 
in cognitive impairment lead to questions regarding possible environ-
mental, experiential, or social factors that influence the development 
and change of neurocognitive performance over time. Cognitive 
 reserve (CR) is an important factor that could be contributing to this 
variability in neuropsychological performances in those with BP. The 
theory of CR asserts that some individuals have more resilient brains 
than others and can sustain higher levels of pathology or damage be-
fore exhibiting significant behavioral symptoms. This is thought to be 
due to accumulation of more efficient, larger, or stronger neural net-
works.16–19 Because CR cannot be easily quantified, proxy measures 
such as premorbid intellectual ability, education, occupational attain-
ment, and leisure activity have been used as surrogate variables and 
are established as standards of CR measurement in the literature.20
CR has most frequently been adopted in research on acquired or 
neurodegenerative conditions, such as Alzheimer’s disease, traumatic 
brain injury, and vascular disease;21–28 however, CR has only recently 
been applied to neuropsychiatric disorders, such as schizophrenia, 
post- traumatic stress disorder, and BP, to help explain variability in 
symptom severity and neuropsychological correlates.1,29,30 In one of 
the few studies examining CR in BP, Forcada and colleagues31 found 
that BP participants with lower neuropsychological functioning (in 
verbal and visual memory and executive functioning) also tended to 
have lower psychosocial functioning, education, occupational attain-
ment, and leisure activities compared to the control group.31 Similarly, 
in 2015, Anaya and colleagues32 studied the relationship between CR 
variables and BP neuropsychological functioning in a large sample of 
200 participants. They reported that higher CR was indeed associated 
with better cognitive functioning in processing speed, working mem-
ory, verbal and visual memory, executive functioning, and attention. 
Therefore, preliminary support exists for the importance of premorbid 
characteristics in the severity of cognitive and functional impairment 
in BP,33 although, to this point, no longitudinal study has explored how 
CR factors may influence change in neurocognitive ability over time 
with a longitudinal research design.
Clearly, examining potential CR effects of neuropsychiatric condi-
tions is difficult, as the accumulation of CR is probably related to the 
clinical symptoms themselves.29 Clinical symptoms that are present 
at an earlier age and severe enough to interfere with daily function-
ing can significantly impact the patient’s ability to complete advanced 
schooling, obtain steady high- level employment, or partake in other 
enriching experiences.34,35 While careful consideration of functional 
impairment should be taken, discovery of psychosocial moderators of 
neuropsychological change over time may have a significant impact on 
treatments and early interventions among individuals with BP symp-
toms. CR may be an important factor to consider, given its implica-
tions in other neurocognitive conditions. Detection of a CR effect on 
neurocognitive change over time may provide important insights into 
cognitive resiliency and how to achieve it.
The present study examined the 5- year longitudinal course of cog-
nitive functioning in a large sample of well- characterized patients with 
BP, and the influence of CR factors on any changes in cognitive func-
tioning over time. First, we hypothesized that group differences would 
exist between groups in terms of neuropsychological test scores, con-
sistent with previous literature. Secondly, based on some of the limited 
evidence, we expected that differences would not exist between BP 
patients and HCs in terms of change in neuropsychological test scores 
over 5 years, and that groups would thus show similar cognitive trajec-
tories. Thirdly, we predicted that individuals with higher CR, as mea-
sured by intellectual ability and educational level, would experience 
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less cognitive decline over time compared to individuals with low CR 
in a sample of patients with BP, similar to findings that suggest that CR 
is a mediator variable between brain injury/pathology and clinical out-
comes. We also explored the effect of age on changes in cognitive test 
scores over time and expected that age would have a small but signif-
icant effect on changes on neuropsychological test scores over time; 
specifically, that older individuals would demonstrate a larger negative 
change in scores compared to younger participants. Additionally, we 
aimed to identify individuals who showed a significant decline in test 
scores (‘decliners’) over time and explored if any CR or clinical variables 
were associated with decline. Again, we hypothesized that low CR 
would be associated with higher rates of decline over the 5- year span.
2  | METHODS
2.1 | Participants
All participants were recruited from the Prechter Longitudinal Study 
of Bipolar Disorder, a large- scale naturalistic study of BP conducted 
at the University of Michigan in Ann Arbor, MI 36,37 and approved 
by the University of Michigan institutional review board. For the 
present study, 159 individuals with BP (type I or II, or not otherwise 
specified [NOS]), and 54 healthy individuals without a history of psy-
chiatric illness (HCs) were included based on having 5 years of lon-
gitudinal data available by July 2015. Two hundred and eighty- two 
participants were eligible for 5- year testing but did not complete it 
due to attrition or other factors (see Results section for analyses com-
paring those who completed 5- year testing and those who did not). 
Individuals were excluded from the longitudinal study if they had a 
history of diagnosed schizophrenia, active substance dependence, or 
a history of significant neurological disease at the time of study entry. 
HC participants were excluded from the study if they met diagnos-
tic criteria for a DSM- IV- TR disorder at any time during the 5- year 
study timeframe, as assessed by biennial clinical interviews (n=11). 
Participant data were not used if evidence of substantial intellectual 
impairment (IQ <70) was present (n=1). Individuals with a history of 
developmental disorder were also screened out at the initial interview. 
Mood states during the neuropsychological assessment were also 
documented at the time at which they entered the study. At base-
line, 54.1% of the BP group were euthymic, 36.5% were considered 
depressed, and 8.8% were considered to be in a hypo/manic state. All 
the HCs were in the euthymic state. Among the BP sample, separate 
chi- square analyses showed that mood state at the time of testing 
(i.e., depressed, manic, or euthymic) was not significantly related to 
overall decline (χ2(2, N=158)=1.10, P=.578) or the number of tests 
on which the performance of participants declined (F=.289, P=.75). 
Further, baseline test performances (P>.05) were not different among 
the specific mood states, other than the measure of visuospatial func-
tioning (Rey- Osterrieth Complex Figure Test [RCFT] copy; F=5.39, 
P=.005). Change in cognitive performance was not related to change 
in depression (Hamilton Depression Rating Scale38 [HDRS]) or mania 
symptoms (Young Mania Rating Scale39 [YMRS]) from baseline to year 
5 (all P>.05). Further, results of ANOVA analyses showed that mood 
state at the time of testing was unrelated to change in cognitive per-
formance across all tests. Thus, those with current mood symptoms 
were included to increase sample size.
2.2 | Clinical assessment
All participants completed an initial psychodiagnostic interview with 
an experienced clinician using the Diagnostic Interview for Genetic 
Studies (DIGS40). Psychiatric diagnoses were then determined through 
best estimate consensus processes in which two MD/PhD level clini-
cians independently evaluated information obtained from the DIGS 
and other available data (e.g., available medical records and self- report 
forms). Educational achievement and other demographic variables 
were obtained through the DIGS interview. Also, information regard-
ing the presence of cerebrovascular disease/risk factors and histori-
cal clinical information (e.g., number of mood episodes, presence of 
psychosis and suicide history) were obtained through the DIGS. The 
HDRS38 and YMRS39 were used to assess mood state at the time of 
testing. The HDRS has 17 items and scores range from 0 to 50, indi-
cating overall depressive symptomatology. The YMRS has 11 items 
and scores range from 0 to 60, indicating overall mania symptomatol-
ogy. Each participant’s medication classes and composite load score 
were determined with methods adapted from other groups,41–45 in 
which higher scores represent a larger medication burden.
2.3 | Cognitive reserve variables
Proxies for CR in our study included education and premorbid intel-
lectual functioning as measured by the vocabulary subtest from the 
Wechsler Abbreviated Scale of Intelligence (see Neuropsychological 
Assessment below). Years of education was used as a continuous 
variable. Higher educational attainment and standardized vocabulary 
scores were considered to be reflective of higher CR.
2.4 | Neuropsychological assessment
All participants completed comprehensive neuropsychological test-
ing at the time of their entry into the longitudinal study (baseline) 
and again 5 years later (year 5), administered by trained research 
associates and supervised by neuropsychologists on the team. The 
neuropsychological test battery was based on previous work by 
Langenecker et al.37 and captured neurocognitive abilities in the areas 
of attention, memory, language, processing speed, executive function-
ing, and motor speed. The test battery has also been used in a number 
of other published articles investigating neuropsychological abilities 
among individuals with BP,10,46–50 addressing separate questions 
about the disorder in cross- sectional analyses. Scores from seven 
neuropsychological tests were selected that emphasize major areas of 
cognitive dysfunction among individuals with BP. These included The 
California Verbal Learning Test- II (CVLT- II; long delay free recall: ver-
bal memory),51 RCFT (copy, immediate, delay: visuospatial integration 
and visual memory),52 Purdue Pegboard (dominant and non- dominant 
hand speed: motor speed/dexterity),53 Wisconsin Card Sorting Test 
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(WCST; total correct: executive functioning),54 Stroop Color and 
Word Test (Color- Word interference subtest: attention/executive 
functioning),55 Controlled Oral Word Association Test (COWAT; FAS 
administration: phonemic verbal fluency),56 Animal Fluency (Animals: 
semantic verbal fluency),56 and Trail Making Test A and B (TMTA and 
TMTB; psychomotor speed and executive functioning). The Wechsler 
Abbreviated Scale of Intelligence (WASI; overall intellectual ability)57 
was administered during the baseline evaluation to provide informa-
tion regarding overall intellectual ability (resulting in an estimated full- 
scale IQ score); however, we used the Vocabulary scaled score from 
the WASI as the measure of intelligence as this has been shown to be 
robust to neurological illness.58,59
2.5 | Data analyses
Analyses were completed using the IBM Statistical Package for Social 
Sciences (Version 21) and Statistical Analysis System. t- tests or chi- 
square tests were used to determine the significance of demographic 
differences between the BP and HC groups. Raw scores were con-
verted to Z- scores based on mean HC group scores at baseline and 
year 5. Paired t-test analyses were used to compare the BP and HC 
groups in terms of their neuropsychological test scores at baseline, 
and again at year 5. Change scores were created by calculating the 
difference in Z- scores between baseline testing and year 5 testing. 
Next, we identified decliners (n=120) as individuals with change 
scores at least 1.5 standard deviations (SDs) below the HC mean on 
any of the cognitive tests. A change score of <1.5 SD below the HC 
mean was chosen as a cut- off to represent a clinical change in per-
formance. Those who did not demonstrate a decline of >1.5 SD were 
considered non- decliners (n=104). T- test analyses of the decliners and 
non- decliners were completed to further assess the significance of dif-
ferences among groups in terms of CR variables. We used chi- square 
and t- test analyses to compare the BP decliners and non- decliners on 
clinical variables including cerebrovascular risk factor/disease vari-
ables. Finally, variable regression models were used to determine the 
relationship between changes in test scores over the 5- year period, as 
well as the influence of CR variables. As previously noted, CR variables 
included in our analyses were education and IQ.
3  | RESULTS
There were no significant differences between the BP and HC groups 
in terms of education, age, gender, handedness, WASI full- scale IQ or 
WASI Vocabulary standard score at study entry. Descriptive statistics 
are presented in Table 1.
We compared participants who completed 5- year  testing (com-
pleters; n=283) to those who did not complete it, despite being 
enrolled in the study for 5 years (non- completers; n=282) to contextu-
alize this sample in terms of attrition. The completers had similar full- 
scale IQ (P=.27) and  education (P=.19) to non- completers but were 
more likely to be older (mean(SD)=38.97 (13.13) vs mean(SD)=35.90 
(14.11); t(237)=−2.68, P=.01) and male (P=.0009).
Next, when differences between groups for neuropsychological 
test scores at baseline testing and year 5 testing were examined, the 
BP group showed significantly lower scores on seven of 13 test scores 
at baseline, and six of 13 test scores analyzed at year 5 as compared to 
the HC group. Please see Table 2.
To provide an indicator of overall relative change, change scores 
were created by calculating the difference in Z- scores for all neuro-
psychological tests between baseline testing and year 5 testing. See 
Figure 1. Change scores for the neuropsychological test variables did 
not differ between the BP and HC groups, with the exception of visu-
ospatial skills (RCFT copy) and the delayed visual memory score (RCFT 
delay), which revealed an improvement in performance for BP  patients, 
but not HCs (t=−2.07, P=.04 and t=−2.70, P=.007, respectively; see 
Table 3). Immediate visual memory (RCFT immediate) showed a trend 
toward significance (t=−1.97, P=.05).
Individual participants were considered ‘decliners’ if they obtained 
a change score that was at least 1.5 SDs below the mean HC change 
TABLE  1 Demographic variables; mean 
and standard deviation (SD)
Bipolar disorder I, II, 
NOS: mean (SD)/%
Healthy controls: 
mean (SD)/%
Value (t or 
chi- square) P
Demographics
Education 15.33 (2.32) 15.85 (2.17) 1.44 .15
Gender (female) 74% 63% 2.20 .14
Age 40.70 (12.03) 36.78 (14.88) −1.95 .05
Right hand dominance 86.1% 86.8% 0.02 .90
WASI Vocabulary SS 12.65 (2.74) 12.40 (2.99) −0.55 .59
Clinical variables
HDRS (baseline) 8.92 (6.18) 1.14 (1.53)* −8.96 <0.001*
HDRS (year 5) 8.26 (5.54) 1.85 (3.29)* −8.02 <0.001*
YMRS (baseline) 2.70 (3.43) 0.34 (0.71)* −4.94 <0.001*
YMRS (year 5) 3.27 (4.06) 0.93 (2.67)* −3.96 <0.001*
*Significantly different at P<.05. NOS, bipolar disorder not otherwise specified; WASI, Wechsler 
Abbreviated Scale of Intelligence; SS, scaled score; HRDS, Hamilton Depression Rating Scale; YMRS, 
Young Mania Rating Scale.
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score on one or more neuropsychological tests (i.e., if they demon-
strated more change in test scores over 5 years than was typical for 
the HC sample). Individual HC means and SDs were used to calculate 
change scores for each test score, at each time point. ‘Non- decliners’ 
included individuals with change scores within the HC range, based 
on the HC change score mean (i.e., those who did not change more 
drastically than the average HC over the 5- year timeframe).
Decliners included 74 individuals from the BP group (46.5% of the 
BP group) and 20 individuals from the HC group (37% of the group). 
Within the decliners, there were no significant differences between 
the BP and HC groups in terms of age, education, WASI Vocabulary 
(estimated verbal IQ) or gender. Within the BP group only, decliner 
status was not associated with any of the demographic or CR vari-
ables. However, we found that the decliners in the BP group had sig-
nificantly lower overall IQ scores than those in the BP non- decliner 
group (P<.001).
Those in the decliner group included a majority who declined on 
at least one cognitive test (n=53, 71.6%), 20.3% who declined on 
two tests (n=15), 4.1% who declined on three tests (n=3), 2.7% who 
 declined on four tests (n=2) and 1.4% who declined on six tests (n=1). 
Within the HC group only, decliner status was associated with edu-
cation, with the decliner group having less education than the non- 
decliners (P=.005, decliners education=M 14.8 [SD 2.4]; non- decliners 
education=M 16.5 [SD 1.8]). Of the HCs who declined, the majority 
declined on one cognitive test (n=13; 65%), 20% declined on two tests 
(n=4) and 15% declined on three tests (n=3).
Although not the main analyses, we examined differences in clin-
ical illness variables between decliners and non- decliners among the 
individuals with BP. See Table S1. There were no illness features that 
were significantly different between the decliner and non- decliner 
groups. Further, there were no differences between the decliners and 
non- decliners in terms of the presence of cerebrovascular disease or 
cerebrovascular risk factors. There also was no difference in total med-
ication load when comparing BP decliners to BP non- decliners. When 
TABLE  2  Independent t-test results comparing 
neuropsychological test scores for bipolar disorder (BP) and healthy 
control (HC) groups at baseline and year 5 visits
Measure
BP I, II, NOS: 
mean (SD); raw 
score
Healthy 
controls: 
mean (SD); 
raw score t value Pr > |t|
Visuospatial integration and visual memory
RCFT copy
Baseline 32.07 (3.31) 33.19 (2.52) 2.29 .023*
5 year 33.55 (3.41) 33.75 (2.66) 0.39 .70
RCFT immediate
Baseline 18.82 (7.06) 22.72 (5.87) 3.66 .000*
5 year 21.65 (7.37) 24.84 (7.53) 2.72 .007*
RCFT delay
Baseline 18.43 (6.82) 22.53 (5.87) 3.95 .000*
5 year 21.56 (7.51) 23.82 (6.89) 1.95 .052
Verbal memory
CVLT total learning
Baseline 52.94 (10.64) 54.53 (11.03) 0.93 .35
5 year 51.39 (11.51) 52.54 (13.62) 0.60 .55
CLVT short delay
Baseline 11.25 (3.18) 11.79 (3.15) 1.09 .28
5 year 11.03 (3.66) 11.43 (3.91) 0.67 .50
CVLT long delay
Baseline 11.67 (2.99) 12.23 (2.97) 1.18 .24
 5 year 11.56 (3.60) 11.59 (4.11) 0.05 .96
Motor dexterity
Peg dominant
 Baseline 14.43 (1.87) 15.62 (2.20) 3.86 .000*
 5 year 14.57 (2.30) 15.96 (2.37) 3.78 .000*
Peg non- dominant
 Baseline 13.36 (1.88) 14.65 (1.58) 4.54 .000*
 5 year 13.68 (2.23) 15.02 (2.17) 3.83 .000*
WCST correct
Baseline 70.17 (13.46) 71.29 (11.38) 0.49 .62
5 year 69.27 (10.89) 68.87 (10.26) −0.24 .81
Stroop
Baseline 0.74 (7.03) 4.16 (8.86) 2.88 .004*
5 year 2.79 (7.09) 6.56 (6.88) 3.39 .001*
COWAT
 Baseline 41.84 (13.07) 42.51 (10.56) 0.34 .74
 5 year 39.06 (13.28) 42.22 (12.75) 1.53 .13
Animals
 Baseline 20.52 (5.90) 41.84 (13.07) 0.53 .60
 5 year 18.13 (5.82) 19.67 (4.97) 1.74 .08
 TMTA
 Baseline 30.70 (11.75) 27.26 (12.68) −1.81 .07
 5 year 29.16 (11.15) 24.06 (10.51) −2.95 .004*
Measure
BP I, II, NOS: 
mean (SD); raw 
score
Healthy 
controls: 
mean (SD); 
raw score t value Pr > |t|
TMTB
Baseline 78.48 (44.00) 59.64 (27.74) −2.90 .004*
 5 year 80.26 (40.68) 60.11 (27.07) 3.36 .001*
*Significant at P≤.05. RCFT copy, Rey- Osterrieth Complex Figure Test 
copy; RCFT immediate, Rey- Osterrieth Complex Figure Test immediate 
memory; RCFT delay, Rey- Osterrieth Complex Figure Test delay memory; 
Peg dominant, Perdue Pegboard speed dominant hand; Peg non- dominant, 
Perdue Pegboard speed non- dominant hand; CVLT total learning, California 
Verbal Learning Test total learning; CVLT short delay, California Verbal 
Learning Test short delay free recall; CVLT long delay, California Verbal 
Learning Test long delay free recall; WCST, Wisconsin Card Sort Test, total 
correct; Stroop, Stroop Color/Word interference total; COWA, Controlled 
Oral Word Association Test; Animals, Semantic Fluency, Animals; TMTA, 
Trail Making Test A; TMTB, Trail Making Test B; NOS, bipolar disorder not 
otherwise specified.
TABLE  2  (Continued)
(Continues)
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considering the entire sample (HCs and BP patients), the results con-
tinued to be non- significant.
Finally, the changes in neuropsychological performance over 
5 years were analyzed at a post hoc level with linear regression mod-
eling. The BP and HC groups were analyzed separately to evaluate 
the influences of IQ and education. Regression models showed that, 
within the HC group, age and baseline verbal IQ influenced change in 
semantic verbal fluency performance (Animals). Specifically, education 
influenced semantic fluency (parameter estimate=0.11, P=.02) and 
with every 10- point increase in IQ, change in semantic verbal fluency 
scores decreased by 0.08 (parameter estimate=−0.08, P=.02). Further, 
baseline verbal IQ influenced change in interference control (Stroop 
parameter estimate=−0.94, P=.02) such that, for every 10- point 
 increase in IQ, change in interference decreased by 0.94. Age and 
 education influenced visuomotor attention (TMTA; parameter esti-
mate age=0.03, P=.004; parameter estimate education=−0.13, P=.03) 
and fine motor dexterity (parameter estimate age=−0.03, P=.008; 
parameter estimate education=0.17, P=.02). Within the BP group, re-
gression analyses indicated that lower IQ score was associated with 
significantly decreased verbal memory scores (CVLT long delay free 
recall; parameter estimate=−0.06, P=.01). Lower education was found 
to be related to attenuated decline on a visuospatial functioning test 
(RCFT copy; parameter estimate=−0.10, P=.04) and simple visuomotor 
attention test (TMTA parameter estimate=−.07, P=.048). Age at the 
time of testing was also included in regression analyses as a covariate, 
and results indicated that age was related to change on specific mea-
sures (see Table 4).
4  | DISCUSSION
The results of this study yielded several notable findings regarding 
change in cognition over 5 years in individuals diagnosed with BP, 
compared to control subjects, as well as important insight into poten-
tial CR factors, particularly in those with BP, using a large sample size 
and longitudinal study design. First, we re- demonstrated that baseline 
neurocognitive deficits exist among those with BP compared to HCs, 
consistent with previous literature.37 Specifically, we showed that sig-
nificantly lower scores were obtained by individuals with BP in terms 
of visuospatial ability, immediate and delayed visual memory, bilateral 
motor speed, attention, executive functioning, and psychomotor speed 
(at baseline, year 5, or both time points). Next, we found that change in 
neurocognitive performance over time did not differ between the BP 
and HC groups (with one exception, which showed slightly improved 
performance for BP patients in delayed visual memory). More broadly, 
we did not find evidence for accelerated decline in the 5- year time-
frame for BP patients, consistent with an interpretation of additive, 
but not compounded or accelerated, effects of age and BP.60 When 
we identified individuals who demonstrated a significant decline on at 
least one cognitive measure, we found that decline was significantly 
associated with lower overall intellectual scores compared to those 
who did not decline within the BP group only. This finding was not 
replicated within the HC decliner group. However, we did not find a 
difference between the BP decliners and BP non- decliners in terms of 
our CR variables (WASI Vocabulary and education). This finding sug-
gests that overall IQ may be protective for general cognitive decline in 
BP, but not traditional CR variables as expected.
Instead, we found verbal IQ (WASI Vocabulary) and education 
were related to changes in specific cognitive domains. Specifically, we 
found that intellectual ability was related to change in performance in 
terms of visuospatial ability, simple visuomotor attention, and verbal 
memory in the BP group, three particularly important skills in every-
day life. Overall, findings supported our hypotheses and indicate that 
there does not seem to be evidence of accelerated cognitive decline 
in BP, and that CR variables were related to change in select areas of 
cognition. The overall lack of cognitive decline could represent a stable 
cognitive endophenotype in BP and warrants future exploration.46,61
Overall, our sample was highly educated and intelligent, with IQ 
scores well into the average and high- average ranges, which may ac-
count for why we did not find change in more of the cognitive domains 
assessed. Additionally, a longer period of time, beyond 5 years, may 
be necessary to detect more significant cognitive change within the 
groups. Since our cohort was relatively young (mean age =41.6 years), 
longer studies and analysis of older individuals with BP are warranted. 
It is possible that older individuals with BP do experience accelerated 
cognitive decline and that our sample was too young to allow us to 
detect this.
F IGURE  1 Neuropsychological test score means at baseline 
(BL) and 5 years for patients with bipolar disorder (BP) (Z- scores). 
All healthy control (HC) data are set to a Z- score of 0. RCFT copy, 
Rey- Osterrieth Complex Figure Test copy; RCFT immediate, Rey- 
Osterrieth Complex Figure Test immediate memory; RCFT delay, 
Rey- Osterrieth Complex Figure Test delay memory; Peg dominant, 
Perdue Pegboard speed dominant hand; Peg non- dominant, Perdue 
Pegboard speed non- dominant hand; CVLT total learning, California 
Verbal Learning Test total learning; CVLT short delay, California Verbal 
Learning Test short delay free recall; CVLT long delay, California 
Verbal Learning Test long delay free recall; WCST, Wisconsin Card 
Sort Test, total correct; Stroop, Stroop Color/Word interference total; 
COWA, Controlled Oral Word Association Test; Animals, Semantic 
Fluency, Animals; TMTA, Trail Making Test A; TMTB, Trail Making 
Test B [Colour figure can be viewed at wileyonlinelibrary.com]
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Our finding that those with a bipolar diagnosis did not expe-
rience an increased decline over 5 years is in support of a growing 
body of new literature,11–13 and also contradictory to previous work 
that has claimed that BP is associated with significant neurocognitive 
 decline.5–9,62 However, our study utilized a large sample of participants 
with BP and longitudinal methods, which may increase the specificity 
and generalizability of our findings to BP groups, given the typical high 
rate of variability between patients. Overall, this finding is important 
to consider in treatment planning and support for middle- aged and 
older adults with BP, as these individuals may start at a lower cognitive 
level, and, with a similar pattern of decline, may reach the point of 
dementia at an earlier age. Specifically, the BP group tended to have 
lower baseline neuropsychological scores compared to HCs, and so 
a ‘normal’ decline in cognition associated with age may lead to more 
significant functional deficits as they may reach an objectively more 
impaired cognitive level, which might also translate into higher levels 
of occupational disability.14
Our study makes a significant contribution to the existing literature 
in that it applies the concept of CR to BP, a highly unique condition 
with a complex constellation of neuropsychological symptoms and 
mood difficulties. Our findings suggest, to some degree, that higher 
intellectual abilities earlier in life may be related to preserved cognitive 
abilities in BP, while traditional CR variables, including verbal IQ and 
education, have a selective effect on visual spatial ability and verbal 
memory. It is possible that CR may provide the same kind of preser-
vation and/or accommodation of neurocognitive difficulties in BP as 
that demonstrated in stroke, traumatic brain injury (TBI), dementia, or 
other conditions affecting cognition. To our knowledge, this is the larg-
est study utilizing a longitudinal design following patients for 5 years 
that exists in the current literature. Although other studies have ex-
plored the relationship between CR variables and neuropsychological 
performance in BP, or change in neuropsychological test scores for 
patients with BP over time, this is the first study to our knowledge to 
integrate both features.
While the current study has a number of strengths, there are a 
few limitations that may reduce the generalizability of our results and 
should be considered for future studies. In particular, this study utilized 
participants taking a variety of psychotropic medications and partici-
pating in psychosocial treatments for BP and with comorbid condi-
tions, as is common in naturalistic studies of this kind. It is possible 
that specific medications, such as lithium, had an effect on neurocog-
nitive functioning in our study, but since we did not detect significant 
Measure BP I, II, NOS: mean (SD) Healthy controls: mean (SD) Pr > |t|
Visuospatial integration and visual memory
RCFT copy 0.37 (1.24) 0.00 (0.79) 0.39*
RCFT immediate 0.24 (0.96) −0.04 (0.71) 0.05
RCFT delay 0.37 (0.92) 0.00 (0.70) 0.007*
Verbal memory
CVLT total learning 0.06 (0.72) 0.00 (0.88) 0.64
CVLT short delay 0.08 (0.85) 0.00 (0.81) 0.52
CVLT long delay 0.20 (0.78) −0.01 (0.81) 0.11
Motor speed/dexterity
Peg dominant −0.04 (0.76) −0.01 (1.13) 0.80
Peg non- dominant 0.21 (0.93) 0.00 (0.98) 0.16
Executive functioning
WCST correct 0.07 (1.75) −0.08 (1.51) 0.61
Stroop −0.16 (1.00) 0.00 (0.85) 0.31
Verbal fluency
COWAT −0.57 (2.08) −0.10 (1.90) 0.14
Animals −0.04 (0.71) −0.22 (1.09) 0.28
Psychomotor speed/executive functioning
TMTA 0.22 (0.87) 0.01 (1.07) 0.17
TMTB 0.08 (1.28) 0.09 (0.74) 0.94
*Significant at P≤.05. NOS, BP not otherwise specified; SD, standard deviation; RCFT copy, Rey- 
Osterrieth Complex Figure Test copy; RCFT immediate, Rey- Osterrieth Complex Figure Test immedi-
ate memory; RCFT delay, Rey- Osterrieth Complex Figure Test delay memory; Peg dominant, Perdue 
Pegboard speed dominant hand; Peg non- dominant, Perdue Pegboard speed non- dominant hand; 
CVLT total learning, California Verbal Learning Test total learning; CVLT short delay, California Verbal 
Learning Test short delay free recall; CVLT long delay, California Verbal Learning Test long delay free 
recall; WCST, Wisconsin Card Sort Test, total correct; Stroop, Stroop Color/Word interference total; 
COWA, Controlled Oral Word Association Test; Animals, Semantic Fluency, Animals; TMTA, Trail 
Making Test A; TMTB, Trail Making Test B.
TABLE  3  Independent t- test comparing 
change scores among bipolar disorder (BP) 
and healthy control (HC) groups
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differences between changes in BP and HC groups over time, it is un-
likely that medications were related to a significant decline in cogni-
tion. Please see Table S1, which illustrates the total medication load BP 
participants reported at the time of their initial assessment. Also, the 
particular neuropsychological test battery utilized in our study was se-
lected for ease of administration and comprehensiveness across cog-
nitive domains known to be affected in BP.63 Administration time and 
participant fatigue generally precluded a longer or more comprehen-
sive test battery. Finally, we included BP participants in various mood 
states in our analyses (euthymic, depressed, and manic), and acute 
mood symptoms may have influenced overall performance on testing. 
However, our preliminary analyses did not find a relationship between 
decline and mood state, and therefore it seems unlikely that mood at 
the time of testing significantly influenced our findings. Future work 
TABLE  4 Regression results showing the significant effect of age on neuropsychological test scores in our sample (all participants).
Measure Group df Parameter estimate Standard error t value Pr > |t|
Visuospatial integration and visual memory
RCFT copy BP 1 0.015 0.008 1.77 0.08
HC 1 −0.003 0.008 −0.35 0.73
RCFT immediate BP 1 0.009 0.006 1.39 0.17
HC 1 0.001 0.007 0.10 0.93
RCFT delay BP 1 0.004 0.006 0.64 0.52
HC 1 0.003 0.007 0.44 0.66
Verbal memory
CVLT total learning BP 1 0.003 0.005 0.67 0.50
HC 1 0.004 0.008 0.45 0.66
CVLT short delay BP 1 −0.004 0.006 −0.70 0.48
HC 1 0.004 0.008 0.58 0.56
CVLT long delay BP 1 0.002 0.005 0.33 0.74
HC 1 0.010 0.008 1.29 0.20
Motor speed/dexterity
Peg dominant BP 1 −0.016 0.005 −3.12 0.002*
HC 1 −0.027 0.010 −2.78 0.008*
Peg non- dominant BP 1 −0.012 0.006 −1.90 0.06
HC 1 −0.019 0.009 −2.18 0.03*
Executive functioning
WCST correct BP 1 0.009 0.012 0.75 0.46
HC 1 0.018 0.015 1.17 0.25
Stroop BP 1 0.001 0.007 0.13 0.89
HC 1 0.013 0.008 1.78 0.81
Verbal fluency
COWAT BP 1 −0.040 0.013 −2.99 0.003*
HC 1 −0.005 0.019 −0.41 0.78
Animals BP 1 −0.004 0.007 −0.57 0.57
HC 1 0.003 0.007 0.52 0.61
Psychomotor speed/executive functioning
TMTA BP 1 0.015 0.006 2.51 0.013*
HC 1 0.025 0.008 3.05 0.004*
TMTB BP 1 0.011 0.009 1.21 0.23
HC 1 0.000 0.007 −0.02 0.98
*Significant at P≤.05. BP, bipolar disorder; HC, healthy control; RCFT copy, Rey- Osterrieth Complex Figure Test copy; RCFT immediate, Rey- Osterrieth 
Complex Figure Test immediate memory; RCFT delay, Rey- Osterrieth Complex Figure Test delay memory; Peg dominant, Perdue Pegboard speed domi-
nant hand; Peg non- dominant, Perdue Pegboard speed non- dominant hand; CVLT total learning, California Verbal Learning Test total learning; CVLT short 
delay, California Verbal Learning Test short delay free recall; CVLT long delay, California Verbal Learning Test long delay free recall; WCST, Wisconsin Card 
Sort Test, total correct; Stroop, Stroop Color/Word interference total; COWA, Controlled Oral Word Association Test; Animals, Semantic Fluency, Animals; 
TMTA, Trail Making Test A; TMTB, Trail Making Test B.
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may focus on further characterizing the BP participants who showed 
evidence of decline over our 5- year timeframe. Use of additional sta-
tistical methods (i.e., cluster analyses, etc.) may provide evidence of 
decliner subtypes, offering more precise ways to identify those in need 
of future support. Other factors such as substance abuse, history of 
traumatic brain injury, illness duration, or cardiovascular risk are also 
important considerations for future research, although these were be-
yond the scope of our current work.
It is possible that our findings were influenced by test−retest vari-
ability in our sample. However, our decision to use a change score cut-
off of 1.5 SD below the mean makes it likely that our findings reflect 
meaningful differences, particularly as we utilized standard neuropsy-
chological measures that are widely accepted in the field and report 
strong test−retest reliability.
In summary, the present study demonstrated that neurocognitive 
deficits exist among individuals with BP, though there is generally a 
high degree of heterogeneity and variability among patients. These 
deficits seem to be present early in the disorder, but do not progress at 
a more rapid rate than that experienced by a ‘normally’ aging healthy 
adult sample with no psychiatric illness. Further, higher intellectual 
ability may selectively preserve cognitive abilities over time, particu-
larly for individuals with BP and an above- average IQ. Traditional CR 
factors (WASI Vocabulary and education) were only partially influential 
for decline. We would like to emphasize that it is quite difficult to ex-
amine CR variables in this population, as the accumulation of CR may 
be directly impacted by the presentation of disruptive psychological 
symptoms at a young age.
Our findings provide valuable insight for providers and family 
members working with patients experiencing BP cognitive symptoms. 
Specifically, cognitive training groups or other rehabilitation treat-
ments may be quite beneficial for some BP subgroups, and perhaps 
less necessary for others. Overall, our findings highlight the impor-
tance of intellectual engagement in those with neuropsychiatric ill-
ness, which may provide some defense against functional decline with 
age. This is only a speculation based on a small, but growing, body of 
literature, however, and significantly more research is needed in this 
area for continued understanding of the relationship between premor-
bid intellectual ability, neurocognitive symptoms of BP, and functional 
decline over time.
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